Meeting
2020 ASCO Virtual Scientific Program
The landscape of genomic alterations detected in serial circulating tumor DNA (ctDNA) in clinical progressive metastatic breast cancer.
Authors
Saya Jacob
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Saya Jacob , Andrew A. Davis , Lorenzo Gerratana , Ami N. Shah , Neelima Katam , Qiang Zhang , Firas Wehbe , Lisa E. Flaum , Kalliopi P. Siziopikou , Leonidas C. Platanias , William John Gradishar , Massimo Cristofanilli , Amir Behdad
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1084)
DOI
10.1200/JCO.2020.38.15_suppl.1084
Abstract #
1084
Poster Bd #
169
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with metastatic breast cancer (mBC).
First Author: Lajos Pusztai
Poster
2019 ASCO Annual Meeting
Next-generation sequencing (NGS) results among hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC) patients treated with a CDK4 & 6 inhibitor: A retrospective observational study based on real‑world data.
First Author: Erika Paige Hamilton
Poster
2023 ASCO Annual Meeting
ESR1 mutational landscape and impact of co-existing resistance variants on clinical outcomes in patients with metastatic breast cancer.
First Author: Arielle J Medford
Poster
2020 ASCO Virtual Scientific Program
Cell-free DNA comparative analysis of hormone receptor-positive, first-line metastatic breast cancer genomic landscape in the United States and China.
First Author: Huiping Li